J4G-MC-JZVD (FORAGER-2): A Phase 3, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Vepugratinib Combined With Enfortumab Vedotin and Pembrolizumab in Adults With Untreated Locally Advanced or Metastatic Urothelial Carcinoma With an FGFR3 Genetic Alteration

Objective

Clinical Trial Details

Principal Investigator(s)

Ryan Vaca, MD

Clinical Trial Categories

• Cancer
• Prostate Cancer

Contact

Medical Oncology Research Coordinators at 605-322-3295
or medoncresearch@avera.org